Nuvectis Pharma Inc (NVCT)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 169.29M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 11.80
52W Low
$ 4.44
Dividend Yield
0.00%
Beta
-0.27
Technicals
50-Day MA
7.326
200-Day MA
7.4995
52 Week High
11.8
52 Week Low
4.44
About NVCT
Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.
Employees
13
Headquarters
Fort Lee, NJ
CEO
Mr. Ron Bentsur M.B.A.
Latest News
Should you hold or exit NVCT now - IPO Watch & Weekly Top Stock Performers List - Newser
15 hours ago • Google News